Category Archives: HIV

The Case for Cost-Effectiveness

It appears I’ve engaged in a bit of a bait and switch.  At the end of my last post I promised to address the issue of HIV-related health expenditures dominating global health budgets and the adverse effects of such overfunding.  … Continue reading

Posted in Cost-effectiveness, global health, HIV, HIV/AIDS, life expectancy, priority-setting | 3 Comments

Risk Externalities, Sleeping Around, and HIV

One of the basic results of normative economics is that market outcomes under competition are socially optimal – the common claim is that the free market is efficient. Calling market results “good” is certainly a value judgment, but this claim … Continue reading

Posted in efficiency, externalities, herd immunity, HIV | 2 Comments